Russell Investments Group Ltd. lessened its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 50.3% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 112,460 shares of the company’s stock after selling 113,771 shares during the period. Russell Investments Group Ltd.’s holdings in Nu Skin Enterprises were worth $5,478,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Schroder Investment Management Group increased its holdings in shares of Nu Skin Enterprises by 29.1% in the 2nd quarter. Schroder Investment Management Group now owns 63,135 shares of the company’s stock valued at $3,113,000 after purchasing an additional 14,248 shares in the last quarter. Edgestream Partners L.P. grew its holdings in shares of Nu Skin Enterprises by 106.7% during the second quarter. Edgestream Partners L.P. now owns 135,275 shares of the company’s stock worth $6,672,000 after buying an additional 69,818 shares in the last quarter. Delek Group Ltd. grew its holdings in shares of Nu Skin Enterprises by 53.0% during the second quarter. Delek Group Ltd. now owns 573,900 shares of the company’s stock worth $27,653,000 after buying an additional 198,900 shares in the last quarter. Handelsinvest Investeringsforvaltning grew its holdings in shares of Nu Skin Enterprises by 73.8% during the second quarter. Handelsinvest Investeringsforvaltning now owns 47,000 shares of the company’s stock worth $2,318,000 after buying an additional 19,954 shares in the last quarter. Finally, Wasatch Advisors Inc. grew its holdings in shares of Nu Skin Enterprises by 98.7% during the second quarter. Wasatch Advisors Inc. now owns 430,104 shares of the company’s stock worth $21,213,000 after buying an additional 213,591 shares in the last quarter. Institutional investors own 73.95% of the company’s stock.

Shares of NUS traded up $0.15 during mid-day trading on Friday, hitting $44.43. The company had a trading volume of 10,055 shares, compared to its average volume of 526,845. The business’s 50-day simple moving average is $40.56 and its 200-day simple moving average is $48.47. The company has a quick ratio of 1.20, a current ratio of 1.90 and a debt-to-equity ratio of 0.52. Nu Skin Enterprises, Inc. has a 1-year low of $35.03 and a 1-year high of $85.75. The stock has a market cap of $2.43 billion, a PE ratio of 12.63, a P/E/G ratio of 1.45 and a beta of 0.77.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Tuesday, August 6th. The company reported $0.83 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.83. Nu Skin Enterprises had a net margin of 4.79% and a return on equity of 24.73%. The business had revenue of $623.50 million for the quarter, compared to analysts’ expectations of $622.32 million. During the same period last year, the company earned $0.95 earnings per share. The company’s quarterly revenue was down 11.5% on a year-over-year basis. On average, sell-side analysts expect that Nu Skin Enterprises, Inc. will post 3.26 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 11th. Investors of record on Friday, August 30th were given a $0.37 dividend. The ex-dividend date was Thursday, August 29th. This represents a $1.48 annualized dividend and a dividend yield of 3.33%. Nu Skin Enterprises’s dividend payout ratio is presently 42.05%.

A number of equities research analysts have recently commented on NUS shares. ValuEngine upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “sell” rating in a report on Thursday, August 1st. Jefferies Financial Group downgraded shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating and set a $40.00 price target for the company. in a report on Wednesday, July 17th. Citigroup lowered their price target on shares of Nu Skin Enterprises from $86.00 to $52.00 and set a “buy” rating for the company in a report on Thursday, July 18th. DA Davidson lifted their price target on shares of Nu Skin Enterprises to $42.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Finally, Stifel Nicolaus set a $39.00 price target on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a report on Wednesday, August 7th. Three analysts have rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $53.75.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.

Further Reading: What is a Stop Order?

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.